Talat Imran, Chief Executive Officer at Rani Therapeutics, sold RANI on Dec 27, 2024
Data as of Oct 16
▼ SELL$11.3K8,014 shares at $1.41Talat Imran Chief Executive OfficerRANI Rani Therapeutics Holdings, Inc.
- Traded
- Dec 27, 2024
- Disclosed
- Jul 21, 2026
- Filed
- 571 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RANI since disclosure
−7.3%
after the sale
Similar stocks (XLV) since disclosure
+10.3%
XLV — its sector index fund
Change in closing price from Jul 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.